Literature DB >> 20830506

Cyp1B1 mRNA expression in correlation to cotinine levels with respect to the Cyp1B1 L432V gene polymorphism.

Simone Helmig1, Jens Udo Seelinger, Monika Philipp-Gehlhaar, Juliane Döhrel, Joachim Schneider.   

Abstract

Cytochrome P450 1B1 (CYP1B1) is involved in the activation of a broad spectrum of procarcinogens. An association of the Cyp1B1 Leu432Val polymorphism with cancer as well as an impact on the enzyme activity has been described. To study gene-environmental interactions we investigated the quantitative Cyp1B1 mRNA expression in smokers (N = 102) and non-smokers (N = 192) with regards to the Cyp1B1 L432V gene polymorphism. Tobacco smoke exposure was assessed by serum cotinine levels. Genotypes were analysed by melting curve analysis and quantification of Cyp1B1 mRNA by real-time PCR. In comparing Cyp1B1 expression, significant differences between the two homozygote genotypes *1/*1 and *3/*3 (0.105 ± 0.019; n = 26 vs. 0.051 ± 0.017; n = 14; P = 0.039) and between the heterozygote genotype *1/*3 and *3/*3 (0.121 ± 0.029; n = 55 vs. 0.051 ± 0.017; n = 14; P = 0.039) of smokers were revealed. According to the serum cotinine levels, three subgroups (low; medium; high) were build. The group "high" (0.248 ± 0.089; n = 32) showed proportionally high Cyp1B1 mRNA expression compared to "medium" (0.101 ± 0.024; n = 33), "low" (0.086 ± 0.015; n = 32) and non-smokers (0.084 ± 0.007; n = 176). This result was reflected in the homozygote *1/*1 and the heterozygote *1/*3 genotypes. In contrast the homozygote *3/*3 genotype was missing the high Cyp1B1 mRNA expression in the cotinine subgroup "high". Our results suggest that genotypes carrying the C-allele (*1/*1 and *1/*3) at Cyp1B1 Leu432Val polymorphism show a higher response to environmental factors, such as tobacco smoke than homozygote *3/*3 genotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830506     DOI: 10.1007/s10654-010-9505-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  28 in total

1.  Detection of cytochrome P450 1B1 Bfr I polymorphism: genotype distribution in healthy German individuals and in patients with colorectal carcinoma.

Authors:  E Fritsche; T Brüning; C Jonkmanns; Y Ko; H M Bolt; J Abel
Journal:  Pharmacogenetics       Date:  1999-06

2.  Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.

Authors:  Y Ko; J Abel; V Harth; P Bröde; C Antony; S Donat; H P Fischer; M E Ortiz-Pallardo; R Thier; A Sachinidis; H Vetter; H M Bolt; C Herberhold; T Brüning
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

3.  Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers.

Authors:  J C Willey; E L Coy; M W Frampton; A Torres; M J Apostolakos; G Hoehn; W H Schuermann; W G Thilly; D E Olson; J R Hammersley; C L Crespi; M J Utell
Journal:  Am J Respir Cell Mol Biol       Date:  1997-07       Impact factor: 6.914

4.  Influence of the Cyp1B1 L432V gene polymorphism and exposure to tobacco smoke on Cyp1B1 mRNA expression in human leukocytes.

Authors:  Simone Helmig; Bahar Hadzaad; Juliane Döhrel; Joachim Schneider
Journal:  Drug Metab Dispos       Date:  2009-04-06       Impact factor: 3.922

5.  Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.

Authors:  Majorie B M van Duursen; J Thomas Sanderson; Martin van den Berg
Journal:  Toxicol Sci       Date:  2005-01-19       Impact factor: 4.849

6.  Cytochrome P450 1B1 mRNA measured in blood mononuclear cells by quantitative reverse transcription-PCR.

Authors:  C Dassi; S Signorini; P Gerthoux; M Cazzaniga; P Brambilla
Journal:  Clin Chem       Date:  1998-12       Impact factor: 8.327

7.  Relative quantification of Cytochrome P450 1B1 gene expression in peripheral leukocytes using lightcycler.

Authors:  Simone Helmig; Bahar Hadzaad; Juliane Döhrel; Joachim Schneider
Journal:  Cancer Genomics Proteomics       Date:  2009 Jan-Feb       Impact factor: 4.069

8.  Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers.

Authors:  James H Kim; Mark E Sherman; Frank C Curriero; F Peter Guengerich; Paul T Strickland; Thomas R Sutter
Journal:  Toxicol Appl Pharmacol       Date:  2004-09-15       Impact factor: 4.219

9.  Cytochrome P450 1B1 mRNA levels in peripheral blood cells and exposure to polycyclic aromatic hydrocarbons in Chinese coke oven workers.

Authors:  Tomoyuki Hanaoka; Yuko Yamano; Guowei Pan; Kunio Hara; Masayoshi Ichiba; Jiusong Zhang; Shujuan Zhang; Tiefu Liu; Landi Li; Ken Takahashi; Jun Kagawa; Shoichiro Tsugane
Journal:  Sci Total Environ       Date:  2002-09-16       Impact factor: 7.963

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  6 in total

Review 1.  Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.

Authors:  Shanbeh Zienolddiny; Vidar Skaug
Journal:  Lung Cancer (Auckl)       Date:  2011-12-29

2.  Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users.

Authors:  Min-Ae Song; Jo L Freudenheim; Theodore M Brasky; Ewy A Mathe; Joseph P McElroy; Quentin A Nickerson; Sarah A Reisinger; Dominic J Smiraglia; Daniel Y Weng; Kevin L Ying; Mark D Wewers; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-17       Impact factor: 4.254

Review 3.  Effects of tobacco smoking and nicotine on cancer treatment.

Authors:  William P Petros; Islam R Younis; James N Ford; Scott A Weed
Journal:  Pharmacotherapy       Date:  2012-10       Impact factor: 4.705

4.  Common genetic variation in CYP1B1 is associated with concentrations of T₄, FT₃ and FT₄ in the sera of polycystic ovary syndrome patients.

Authors:  Shien Zou; Qing Sang; Huan Wang; Ruizhi Feng; Qiaoli Li; Xinzhi Zhao; Qinghe Xing; Li Jin; Lin He; Lei Wang
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

5.  Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia.

Authors:  Bruno Almeida Lopes; Mariana Emerenciano; Bruno Alves Aguiar Gonçalves; Tállita Meciany Vieira; Ana Rossini; Maria S Pombo-de-Oliveira
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

6.  Effects of SNPs (CYP1B1*2 G355T, CYP1B1*3 C4326G, and CYP2E1*5 G-1293C), smoking, and drinking on susceptibility to laryngeal cancer among Han Chinese.

Authors:  Jianhua Jin; Faming Lin; Shiyu Liao; Qiyu Bao; Liyan Ni
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.